Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Insulin resistance linked to obesity may increase COVID-19 severity.

Blocking the ATX-LPA pathway may improve insulin sensitivity and mitochondrial function in obesity.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Early balding men may have insulin resistance, but lifestyle changes can help.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Lower ghrelin levels and certain gene variations may increase acne risk.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

Darkened knuckles can be an early sign of insulin resistance.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

Different types of polycystic ovary syndrome show varying levels of insulin resistance, with the 'PHO' type being the most insulin resistant.